Remove DEA Remove Document Remove Policy
article thumbnail

Federal Agency Submits Documents Recommending Rescheduling Cannabis

Veriheal

Department of Health and Human Services released an official 252-page document outlining their reasoning for rescheduling cannabis to Schedule III under the Controlled Substances Act (CSA). The DEA holds the final authority on cannabis rescheduling, and they have yet to state whether they plan on taking this action.

DEA 122
article thumbnail

Intoxicating Hemp Swindle

Project CBD

In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary. “Each ingredient has a well-documented safety profile at the included doses.”

Hemp 232
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis Litigation: Second Circuit Could Force DEA to Re- or Deschedule Marijuana

Canna Law Blog

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling.

DEA 108
article thumbnail

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Cannabis Law Report

Drug Enforcement Agency (“DEA”). Given the alarming and noticeable increase in ayahuasca border seizures in 2020, the main intent of these initial requests was to see how many seizures happened that year and if the government had a specific policy regarding these seizures. Customs Border Patrol (“CBP”) and U.S.

DEA 97
article thumbnail

DEA finally ends fed monopoly on schwaggy research-grade cannabis

SpeedWeed

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. Leafly’s Ben Adlin documented the shockingly poor quality in this 2017 article : Smoking 25% THC, studying 8% THC. DEA finally relents.

DEA 52
article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

article thumbnail

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45